Copyright
©The Author(s) 2024.
World J Clin Pediatr. Mar 9, 2024; 13(1): 88912
Published online Mar 9, 2024. doi: 10.5409/wjcp.v13.i1.88912
Published online Mar 9, 2024. doi: 10.5409/wjcp.v13.i1.88912
Figure 3 Brief summary of the pathogenesis of lung involvement in systemic juvenile arthritis.
BMPR2: Bone morphogenetic protein receptor type II; GM-CSF: Granulocyte-macrophage colony-stimulating factor; IFN: Interferon; IL: Interleukin; ILD: Interstitial lung disease; MAS: Macrophage activation syndrome; PAH: Pulmonary arterial hypertension; PAP: Pulmonary alveolar proteinosis; sJIA: Systemic juvenile idiopathic arthritis; TNF: Tumor necrosis factor.
- Citation: Belozerov KE, Solomatina NM, Isupova EA, Kuznetsova AA, Kostik MM. Systemic juvenile idiopathic arthritis–associated lung disease: A retrospective cohort study. World J Clin Pediatr 2024; 13(1): 88912
- URL: https://www.wjgnet.com/2219-2808/full/v13/i1/88912.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v13.i1.88912